Skip to main content
OpenTrials

Clinical trial condition

Pigmented Villonodular Synovitis

Explore clinical trials studying Pigmented Villonodular Synovitis. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Pigmented Villonodular Synovitis trial results

Completed

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

NCT01207492

Conditions
Diffuse-type Giant Cell Tumor, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +12 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

NCT05349643

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +12 more
Locations
  • AmMax Bio, Clinical Site Sacramento, California, United States
  • AmMax Bio, Clinical Site Miami, Florida, United States
  • AmMax Bio, Clinical Site Houston, Texas, United States
  • AmMax Bio, Clinical Site Camperdown, Australia
View Trial Details
Completed

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

NCT02371369

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Giant Cell Tumors of the Tendon Sheath, +12 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • UCLA Medical Center Santa Monica, California, United States
View all 39 locations
View Trial Details
Completed

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

NCT02471716

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Sarcoma Oncology Research Center LLC Santa Monica, California, United States
  • Stanford Medicine Stanford, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

NCT01643850

Conditions
GCCTS, GCTS, Giant Cell Tumor of Tendon Sheath, +15 more
Locations
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site Denver, Colorado, United States
  • Novartis Investigative Site Washington D.C., District of Columbia, United States
  • Novartis Investigative Site Miami, Florida, United States
View Trial Details
Active, Not Recruiting

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

NCT03069469

Conditions
Advanced Malignant Neoplasm, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +13 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado - Denver Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

NCT05804045

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • Duke University Medical Center Durham, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View all 40 locations
View Trial Details

Related conditions